top of page

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

About the study

NCT Trial Number

NCT03367533

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Yale University

noun_date_3237048.png

Trial Start Date

Nov-18

noun_capsule_138144.png

About the participants

Age seeking

21 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

The study will assess the combined effect of perampanel and ketamine on the anti-depressant response in individuals with treatment resistant depression

Eyes Graffiti

Locations

United States, Connecticut
Yale University
New Haven, Connecticut, United States, 06511

Contact: Naomi Drieson, PhD
203-932-5711 ext 3329
naomi.driesen@yale.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page